//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfilePosts









Loading...
Please take the survey and re-post to help grow response! Thanks. @oncodaily.bsky.social
6h
Explore innovative approaches targeting PRAME+ cancers with Cedrik M. Britten, MD. Learn about the clinical development of TCR T-cell therapies and bispecific T-cell engagers. Learn more and register: https://www.sitcancer.org/edu/edu-sitc-biotech-initiative/eu-io-summit
Join us for the Targets for Cancer IO: A Deep Dive Series—an expert-led webinar program exploring cutting-edge science and therapeutic innovation in immuno-oncology. Learn more about these webinars and register here: https://www.sitcancer.org/edu/webinars/targets-for-cancer-io
Expert SITC speaker Lili Yang, PhD, UCLA is sharing insights on serotonin transporter inhibition at JACI 2026. Explore the latest updates on intratumoral therapies July 22–24, in Kagawa, Japan or virtual. Learn more: https://ow.ly/Ml0i50Z2ek4 OncoDaily
Don’t miss the first webinar in our Deep Dive Series, happening June 30th! Explore the mechanisms and clinical development of PD-1/VEGF bispecifics with expert faculty examining emerging biology, engineering strategies, and the latest clinical data. sitcancer.org/edu/webinars/targets-for-cancer-io
New #JITC review: "Targeting macrophage-driven NK cell immunosuppression to improve cancer immunotherapy" jitc.bmj.com/content/14/6... #cancer #IO 🧪
Opportunities and challenges with myeloid cells in cancer biology! Access in-depth reviews and questions with a new #JITC special series, "Myeloid Cells in Immuno-Oncology", edited by Drs. Dmitry I. Gabrilovich, Jennifer L. Guerriero, and Judith A. Varner. View full series: https://ow.ly/VWMz50ZbbuI
Society for Immunotherapy of Cancer
1h
#CIM – It’s Forward Fund (FF) Friday. Your donation to the FF provides ECS opportunities to share their research w/ IO leaders through SITC travel awards & Early Career Investigator Awards. Your support is launching careers in IO to benefit Cx patients. givebutter.com/sitc-forward...
4d
#CIM – On SITC's Forward Fund Friday, we recognize the opportunities provided via your donations. Providing Early Career Scientists, the funding to share their research through travel awards is catapulting careers in #IO. Contribute and make an impact today. givebutter.com/sitc-forward... #GiveBack
New #JITC article: "Spatially resolved single-cell landscape of tumor immunotypes reveals the central role of interferon signaling and plasmacytoid dendritic cells in triple-negative breast cancer" jitc.bmj.com/content/14/6... #JournalforImmunoTherapyofCancer #cancer #research🧪
1d
3h
6h
4d
4d
4d
4d
Please re-post to reach as many #cancer #immunotherapy #patients as possible!
5d
Society for Immunotherapy of Cancer
Society for Immunotherapy of Cancer
SITC Forward Fund Donations
Empowering the next-generation of investigators and advancing the field of cancer immunotherapy
givebutter.com
Society for Immunotherapy of Cancer
Society for Immunotherapy of Cancer
Society for Immunotherapy of Cancer
Society for Immunotherapy of Cancer
Society for Immunotherapy of Cancer
Society for Immunotherapy of Cancer
Society for Immunotherapy of Cancer
Deb Collyar